Anti-snoring Devices and Snoring Surgery Market

Anti-Snoring Devices and Snoring Surgery Market Outlook (2022 to 2032)

In FY 2021, the anti-snoring devices and snoring surgery market reached a valuation of US$ 21.32 Billion, and is likely to register a Y-o-Y growth rate of 6.0% in 2022, closing at US$ 22.92 Billion. Furthermore, across the 2022 to 2032 period of assessment, growth is expected to accelerate at a whopping 7.5% CAGR, reaching US$ 47.23 Billion.

Factors, such as a sedentary lifestyle, increasing consumption of alcohol and smoking, and consumption of unhealthy & processed foods are leading to a rise in the number of individuals with obesity problems. Obesity-related problems include stroke, type 2 diabetes, heart disease, and certain types of cancers, which are among the leading cause of premature preventable death. In addition, people suffering from obesity may also suffer from snoring issues and sleep apnea.

Rising awareness across developed nations related to the ill effects of snoring and the huge benefits of treatments coupled with a rising count of the geriatric and obese population are the factors that are expected to boost the market growth. Growing cigarette consumption and alcohol intake along with technological developments in designing Anti-Snoring devices are also likely to foster market growth. The demand for antisnoring treatments across developing countries is expected to create growth opportunities in this market.

Report Attributes	Details
Anticipated Base Year Value (2022)	US$ 21.32 Billion
Expected Market Value (2023)	US$ 22.92 Billion
Projected Forecast Value (2033)	US$ 47.23 Billion
Global Growth Rate (2023 to 2033)	7.5% CAGR
Expected Growth Rate of the US Market (2023 to 2033)	7.4% CAGR
Anticipated Growth Rate of the Chinese Market (2023 to 2033)	7.3% CAGR
Prominent Service Players	AccuMED Corp.; Apnea Sciences Corporation; Fisher & Paykel Healthcare; GE Healthcare; ImThera Medical Inc.; Medtronic Plc.; Philips Healthcare; ResMed Inc.; SoBnoMed; Tomed Dr. Toussaint GmbH; Whole You, Inc.

2017 to 2021 Revenue Analysis of Anti-Snoring Devices and Snoring Surgery Market vs. Growth Outlook 2022 to 2032

According to Fact.MR’s report, Anti-Snoring devices and snoring surgery demand exhibited a CAGR of over 3% from 2017 to 2022, topping US$ 19.83 Billion as of 2021. Sales have spiked in the wake of surging incidences of sleep apnea in the past few years. Sleep apnea occurs in about 25% of men and nearly 10% of women, and can affect people of all age groups.

This incidence is especially acute amongst obese people, particularly those aged above 50. Amidst the COVID-19 pandemic, Anti-Snoring devices experienced significant uptake, with studies concluding that patients with obstructive sleep apnea are vulnerable to adverse post-infection outcomes- such as obesity, hypertension and idiopathic pulmonary fibrosis.

Furthermore, as people increasingly lead sedentary lifestyles, sleep disorders are on the rise- leading to growing frequencies of sleep apnea amongst people. Based on these trends, the market for anti-snoring devices and snoring surgery will likely surge at a CAGR of 7.2% from 2022 to 2032.

Key Market Drivers Influencing Anti-Snoring Devices and Snoring Surgery Industry Expansion

Increase in Incidence of Various Sleep Disorders to Foster Market Growth Prospects

Increasing incidence of various sleep disorders will stimulate the global Anti-Snoring Devices market revenue in the coming years. According to the American Sleep Association, approximately 50-70 million US adults have a sleep disorder and out of those, 48% report snoring. Snoring is estimated to affect 40% of women and 57% of men in the US.

The major factors contributing to increasing incidence of snoring are obesity, alcohol consumption, use of sedative medication, chronic nasal congestion, and pregnancy. Thus, rising incidence and awareness about snoring disorders will fuel the market expansion.

Rise in the Geriatric Population to Fuel the Market Growth

The market is expected to expand due to an increase in the geriatric population, as well as increased smoking and alcohol use, technical improvements in Anti-Snoring equipment, and more public awareness. Because the characteristics of weight increase are added in the elderly population.

According to the World Ageing Population study, there were roughly 702.9 million individuals aged 65 and over in 2019, with that figure predicted to rise to 1.5 billion by 2050. As a result of the aforementioned causes, the worldwide market is expected to surge rapidly in forthcoming years.

Key Challenges encountered by Anti-Snoring Devices and Snoring Surgery Industry

High Cost of Custom-Made Oral Appliances to Hamper the Market Growth

High cost of custom-made oral appliances and social stigma associated with snoring are expected to obstruct market growth. In addition, poor efficacy and lack of scientific validation of the Anti-Snoring devices are projected to challenge the Anti-Snoring devices and snoring surgery market during the forecast period.

Limited Awareness Regarding the Serious Side Effects to Hinder the Market Growth

There is limited awareness regarding the serious side effects and reasons for snoring in developing nations such as India and Brazil. This factor could significantly restrain the growth of Anti-Snoring devices in the coming years. Additionally, lower diagnosis and awareness regarding side effects of snoring in emerging nations to limit the market growth.

Country-wise Analysis

How will the U.S Perform in the Global Anti-Snoring Devices and Snoring Surgery Industry Landscape?

Increase in Prevalence of Sleep Apnea to boost Market Growth

The Anti-Snoring market is presently dominated by North America, with the US and Canada yielding substantial growth opportunities. As of 2019, the market in the US contributed US$ 8.3 Billion in revenue to the North American landscape.

According to the Sleep Foundation, around 57% of males and 40% females snored as of 2019. Furthermore, according to the Centers for Disease Control and Prevention, the obesity prevalence in the United States was at 42.4% in 2019, up 26% since 2008.

Recently, in February 2021, the Food & Drug Administration authorized marketing of the eXciteOSA device to alleviate incidences of mild obstructive sleep apnea in patient ages 18 or above. Such initiatives are widening opportunities for Anti-Snoring devices sales in the country. According to Fact.MR, the U.S is expected to expand at a CAGR of 7.4% until 2032.

How will the Growth of Anti-Snoring Devices and Snoring Surgery Market Escalate across China?

Ever-Increasing Population with Snoring Problems to Enhance the Market Prospects

China's Anti-Snoring device industry accounts for a major portion of the Asian Anti-Snoring device industry's revenue. Due to factors such as an ever-increasing population with snoring problems, the presence of key market players in the region, and a large gap between the number of patients who have been treated and those who have yet to be treated, it is expected to grow substantially.

China's healthcare environment is improving at a rapid pace, with the market for Anti-Snoring gadgets and snoring surgery increasing at an exponential rate. Furthermore, the country is home to prominent e-Commerce businesses (such as Alibaba), indicating that Anti-Snoring devices have a strong online sales potential. Nearly 50% of Asian market revenue will be generated by China. According to Fact.MR, China is expected to expand at a CAGR of 7.3% until 2032.

Country-wise Forecast CAGRs for the Anti-Snoring Devices and Snoring Surgery Market

Country	CAGR
US	7.4%
China	7.3%
UK	7.2%
India	7.3%
Germany	7.1%

Category-wise Insights

Which is the Most Sought-after Device Category?

Increased Demand of CPAP Machines to Boost the Segment’s Growth

In terms of device, continuous positive airway pressure (CPAP) devices segment is prospective to earn greater traction, expanding at a CAGR of 7.3% over the forecast period. In the midst of this epidemic, demand for CPAP machines and masks is likely to grow, as CPAP equipment have been found to help manage COVID-19 symptoms including breathing difficulty.

In situations of airway obstructions, continuous positive airway pressure (CPAP) devices are utilized to force air into the clogged airways and open them up. According to Fact.MR, CPAP devices will likely account for 1/3rd of global revenue.

Which Segment will Remain Dominant in the Surgical Procedure Category?

UPPP Segment to Enhance Growth Prospects

According to Fact.MR’s data, preference for uvulopalatopharyngoplasty (UPPP) surgery captured 41% revenue share in 2021, expanding at a CAGR of 7.2% over the forecast period. UPPP can be performed by an ENT specialist to address large or elongated uvula, loud snoring and OSA.

Long-term relief from airway obstruction, higher oxygen intake levels during sleep, improved snoring and lowered blood pressure are some of the key benefits resulting from UPPP therapy.

Anti-Snoring Devices and Snoring Surgery Market- Competitive Landscape

Prominent players in the Anti-Snoring Devices and Snoring Surgery Industry are taking advantage of the rapidly increasing demand in various applications. To further their outreach, players are relying on collaborations, partnerships and acquisitions with existing small, medium and large-scale vendors. Some prominent market developments are as follows :

• In December 2020, Signifier, a British start-up biotechnology company announced to launch its novel Anti-Snoring device in the US market. The company aimed to reach a target funding of US$ 100 Bn for the same.
• In July 2020, Fisher & Paykel Healthcare inaugurated its 4th research and manufacturing facility at its Daniell Building in New Zealand. This expansion is expected to aid the company in continuing developing and delivering leading healthcare solutions associated with sleep disorders.
• In April 2019, Zyppah received the US FDA approval to market its oral anti snoring device in the US. The company received an over-the counter device approval for marketing of the device.

Key Segments Covered in the Anti-Snoring Devices and Snoring Surgery Industry Survey

• Anti-Snoring Devices and Snoring Surgery by Device :

  • Mandibular Advancement Anti-Snoring Devices (MAD)
  • Tongue Stabilizing Anti-Snoring Device (TSD)
  • Continuous Positive Airway Pressure (CPAP) Anti-Snoring Devices
  • Others (Nasal and Chin Strips, Straps, Rings, etc.)

• Anti-Snoring Devices and Snoring Surgery by Surgical Procedure :

  • Uvulopalatopharyngoplasty (UPPP) Snoring Surgery
  • Tonsillectomy and Adenoidectomy Snoring Surgery
  • Maxillo-Mandibular and Genloglossus Advancement Surgeries
  • Radiofrequency Ablation (RFA) Snoring Surgery
  • Pillar Procedure with Palatal Implants Snoring Surgery

• Anti-Snoring Devices and Snoring Surgery by Region :

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa